US 11041008
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia
granted A61KA61K38/00A61K38/1793
Quick answer
US patent 11041008 (Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
- Grant date
- Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/00, A61K38/1793, A61K38/2086, A61K45/06